Atenolol hepatotoxicity: Report of a complicated case

Annals of Pharmacotherapy

Volumn 43, Issue 10, 2009, Pages 1719-1723

  Dumortier, Jérôme ^a   Guillaud, Olivier ^a   Gouraud, Aurore ^a   Pittau, Gabriella ^a   Vial, Thierry ^a   Boillot, Olivier ^a   Scoazec, Jean Yves ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Atenolol; Hepatitis; Toxicity

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; ATENOLOL; BILIRUBIN; ESOMEPRAZOLE; GAMMA GLUTAMYLTRANSFERASE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICARDIPINE; PREDNISONE; SULFAMETHOXAZOLE; TACROLIMUS; URSODEOXYCHOLIC ACID; VALGANCICLOVIR;

ACUTE HEPATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; HYPERTENSION; LEUKOPENIA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TEST; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER HISTOLOGY; LIVER TOXICITY; PRIORITY JOURNAL; RECURRENT DISEASE;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; ATENOLOL; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; HYPERTENSION; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 70449488349     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M247     Document Type: Article

References (12)

1. Goldstein S. Beta-blockers in hypertensive and coronary heart disease. Arch Intern Med 1996;156:1267-1276 (Pubitemid 26197698)
2. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1989;31:239-245
3. Corrieri-Baizeau C, Dumortier J, Scoazec JY, et al. Mycophenolate mofetil induced acute hepatitis (letter). Gastroenterol Clin Biol 2002; 26:300.
4. Zimmerman HJ. Drug-induced liver disease. Clin Liver Dis 2000;4:73-96.
5. Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990;11:272-276
6. Larrey D, Henrion J, Heller F, et al. Metoprolol-induced hepatitis: rechallenge and drug oxidation phenotyping. Ann Intern Med 1988;108:67-68
7. Schwartz MS, Frank MS, Yanoff A, Morecki R. Atenolol-associated cholestasis. Am J Gastroenterol 1989;84:1084-1086
8. Tanner LA, Bosco LA, Zimmerman HJ. Hepatic toxicity after acebutolol therapy. Ann Intern Med 1989;111:533-534
9. Clark JA, Zimmerman HJ, Tanner LA. Labetalol hepatotoxicity (letter). Ann Intern Med 1990;113:210-213
10. Chon EM, Middleton RK. Labetalol hepatotoxicity. Ann Pharmacother 1992;26:344-345
11. Yusuf SW, Mishra RM. Hepatic dysfunction associated with atenolol (letter). Lancet 1995;346:192.
12. Hagmeyer KO, Stein J. Hepatotoxicity associated with carvedilol. Ann Pharmacother 2001;35:1364-1366 DOI 10.1345/aph.10239